Local Tech Wire 

Solvay Pharmaceuticals Considers N.C., Georgia for $300M Vaccine Plant

Site Search

Solvay Pharmaceuticals has narrowed its lists of finalists for a $300 million vaccine plant to North Carolina, Georgia, New York and Alabama, according to media reports.

For example, newspapers in Alabama say that state is a finalist for what Alabama officials are calling “Project Bamboo.”

Solvay operates out of Marietta and is a subsidiary of the Belgium-based company Solvay SA. It is expected to pick a plant location early this summer.

North Carolina landed a vaccine plant from Novartis that is being built to meet contracts awarded by the federal government for flu vaccine production. The Novartis facility will be built in Apex.